SEC Form 4 · accession 0001615774-17-001494
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Eric D'Ambrosio
Officer — Chief Financial Officer
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 8:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to purchase)F1 | $5.90 | Mar 31, 2017 | A | 15,000 | A | — | Mar 31, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests in 36 equal monthly installments from March 31, 2017.